Louis Boon
Chief Scientific Officer
Polpharma
Check out the incredible speaker line-up to see who will be joining Louis.
Download The Latest Agenda
Biosimilars Commercialisation Summit Agenda 2019
Conference Day Two
Thursday, March 5th, 2020
9:45 AM Case Study: Manufacturing Biosimilars for Checkpoint Inhibitors
- Ensure biosimilarity and high productivity with upstream process modulation
- Utilise novel SPOT™ and SLIM™ technologies on the CHOBC® platform to reduce COGs
- Combine biosimilar checkpoint inhibitors to reduce healthcare expenditures